144 related articles for article (PubMed ID: 10942237)
21. Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?
Aguirre Palma LM; Gehrke I; Kreuzer KA
Crit Rev Oncol Hematol; 2015 Mar; 93(3):225-36. PubMed ID: 25459668
[TBL] [Abstract][Full Text] [Related]
22. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons.
Bauvois B; Dumont J; Mathiot C; Kolb JP
Leukemia; 2002 May; 16(5):791-8. PubMed ID: 11986939
[TBL] [Abstract][Full Text] [Related]
23. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
24. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
[TBL] [Abstract][Full Text] [Related]
25. Role of angiogenesis in chronic lymphocytic leukemia.
Letilovic T; Vrhovac R; Verstovsek S; Jaksic B; Ferrajoli A
Cancer; 2006 Sep; 107(5):925-34. PubMed ID: 16832815
[TBL] [Abstract][Full Text] [Related]
26. A study of bone marrow neoangiogenesis in chronic lymphocytic leukemia patients.
Lesty C; Baudet S; Charlotte F
Anal Quant Cytol Histol; 2010 Feb; 32(1):11-23. PubMed ID: 20701083
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL).
Aguayo A; Manshouri T; O'Brien S; Keating M; Beran M; Koller C; Kantarjian H; Rogers A; Albitar M
Leuk Res; 2001 Apr; 25(4):279-85. PubMed ID: 11248324
[TBL] [Abstract][Full Text] [Related]
28. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia.
Lyu CJ; Rha SY; Won SC
Yonsei Med J; 2007 Apr; 48(2):171-5. PubMed ID: 17461513
[TBL] [Abstract][Full Text] [Related]
29. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
Molica S; Cutrona G; Vitelli G; Mirabelli R; Molica M; Digiesi G; Ribatti D; Ferrarini M; Vacca A
Leuk Res; 2007 Nov; 31(11):1575-8. PubMed ID: 17485110
[TBL] [Abstract][Full Text] [Related]
30. Endothelial stimulation by small lymphocytic lymphoma correlates with secreted levels of basic fibroblastic growth factor.
Rimsza L; Pastos K; Massey K; Braylan R
Br J Haematol; 2003 Mar; 120(5):753-8. PubMed ID: 12614205
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis is increased in B-cell chronic lymphocytic leukemia.
Peterson L; Kini AR
Blood; 2001 Apr; 97(8):2529. PubMed ID: 11307777
[No Abstract] [Full Text] [Related]
32. Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD).
Wróbel T; Mazur G; Surowiak P; Wolowiec D; Jelen M; Kuliczkowsky K
Pathol Oncol Res; 2003; 9(3):170-3. PubMed ID: 14530810
[TBL] [Abstract][Full Text] [Related]
33. Angiogenic factors in chronic lymphocytic leukemia.
Xia Y; Lu RN; Li J
Leuk Res; 2012 Oct; 36(10):1211-7. PubMed ID: 22727510
[TBL] [Abstract][Full Text] [Related]
34. Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".
Kay NE; Shanafelt TD; Strege AK; Lee YK; Bone ND; Raza A
Leuk Res; 2007 Jul; 31(7):899-906. PubMed ID: 17241660
[TBL] [Abstract][Full Text] [Related]
35. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of microvessel density in multiple myeloma patients.
Ahn MJ; Park CK; Choi JH; Lee WM; Lee YY; Choi IY; Kim IS; Lee WS; Ki M
J Korean Med Sci; 2001 Feb; 16(1):45-50. PubMed ID: 11289400
[TBL] [Abstract][Full Text] [Related]
37. TCTP/HRF pathway and angiogenesis: a feasible intercourse in chronic lymphocytic leukemia.
Yağcı M; Yegin ZA; Akyürek N; Kayhan H; Ozkurt ZN; Sucak GT; Haznedar R
Leuk Res; 2013 Jun; 37(6):665-70. PubMed ID: 23434429
[TBL] [Abstract][Full Text] [Related]
38. Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
Molica S; Vacca A; Tucc L; Ribatti D
Haematologica; 2005 May; 90(5):698-700. PubMed ID: 15921392
[TBL] [Abstract][Full Text] [Related]
39. [The clinical significance of angiogenesis in the bone marrow of acute leukemia patients].
Ye XJ; Wang LJ; Lin MF; Ding W
Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):486-9. PubMed ID: 12921610
[TBL] [Abstract][Full Text] [Related]
40. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
